SARS COVID-19 Vaccine Study

Vanderbilt University Medical Center (VUMC) is recruiting volunteers for a randomized controlled phase II clinical trial to help determine the prevalence of systemic allergic reactions (SARS) to the two-dose COVID-19 mRNA vaccines made by Pfizer-BioNTech and Moderna Inc. 

Are you a male or non-pregnant female 18-69 years of age who would like to receive the Pfizer or Moderna vaccine for COVID-19?  

We are currently looking for healthy and allergic volunteers to participate in a research study!

Please, click the Survey link to see if you qualify: https://redcap.vanderbilt.edu/surveys/?s=NDA3WFCDAC


SJS Adv Sml

Interested in this study? 

Take the survey here

or email: drugsafetyresearch@vumc.org

DRESS SURVIVOR STUDY

https://medsites.vumc.org/dresssurvivorstudy/dress-study-home

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a serious life threatening but potentially preventable drug-induced disease.

DRESS is related to common drugs such as anti-infective drugs(vancomycin, trimethoprim-sulfamethoxazole (Bactrim), dapsone, minocycline, antiretrovirals such as nevirapine and raltegravir and others), anticonvulsants and drugs for mood disorders (lamotrigine, phenytoin, carbamazepine, oxcarbazepine), and drugs for gout (allopurinol) as well as many other drugs.

Strong genetic risk factors have been associated with DRESS that open a pathway to prediction, prevention and improved diagnosis, however many drugs require further research to help in the discovery of new genetic markers, to understand additional genetic factors that explain why not everyone carrying the primary risk gene gets dress and to increase the widespread availability of preventive and diagnostic genetic markers.

If you are interested in this study, please complete the survey at the link below:

DRESS Survivor Study